nach oben

Erschienen in:

01.10.2015 | Review

The complex interplay between Notch signaling and Snail1 transcription factor in the regulation of epithelial–mesenchymal transition (EMT)

Notch and Snail1 in epithelial–mesenchymal transition (EMT)

verfasst von: M. Brzozowa-Zasada, PhD, A. Piecuch, MSc, O. Segiet, MD, Prof. K. Stęplewska, Prof. A. Gabriel, Prof. R. Wojnicz

Erschienen in: European Surgery | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Summary

Background

The epithelial–mesenchymal transition (EMT) is a highly coordinated process observed during embryonic development and adult tissue repair. It is characterized by the loss of cell–cell adhesion and apicobasal polarity, and the transition to a cell type with a spindle-like phenotype able to migrate through the basal membranes.

Methods

This review article includes available date from peer-reviewed publications associated with the role of Notch signaling and Snail1 transcription factor in activation and regulation of EMT.

Results

Growing evidences in the past few years demonstrated a significant role of Notch in EMT activation. It is not surprising because this pathway is the nexus of a unique and versatile signaling network, that regulates and is regulated by a variety of cellular mechanisms highly dependent on the biological context—especially tissue microenvironment. This compartment sends signals promoting and regulating EMT, which usually acts as a transcriptional repressors. Among them, Snail1 has been shown to be crucial for cellular movement during cancer progression and metastasis. In cancer patients, increased level of Snail1 is usually connected with poor clinical outcome, probably due to downregulation of E-cadherin expression. Moreover, the continuous expression of E-cadherin during developmental EMT in Snail1-deficient mouse embryos clearly supports the idea that its transcriptional repression is mostly related to Snail1 activity.

Conclusion

Cooperation of Notch signaling and Snail1 plays very significant role in such pathologies as wound healing and cancer development. Nevertheless, they are also involved in tissue embryonic development.

Vorheriger Artikel Surgery, limos and shine keep things going

Nächster Artikel Transanal endoscopic microsurgery in treatment of small rectal T1 high-risk, T2 and T3 carcinomas combined with radiochemotherapy

Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial–mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119:1438–49. doi:10.1172/JCI38019.PubMedCentralCrossRefPubMed

Davis FM, Stewart TA, Thompson EW, Monteih GR. Targeting EMT in cancer: opportunities for pharmacological intervention. Trends Pharmacol Sci. 2014;35:479–88. doi:10.1016/j.tips.2014.06.006CrossRefPubMed

Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293–9. doi:10.1111/j.1349-7006.2009.01419.xCrossRefPubMed

Noseda M, McLean G, Niesses K, et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res. 2004;94:910–7.CrossRefPubMed

Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer. 2010;102:351–60. doi:10.1038/sj.bjc.6605486PubMedCentralCrossRefPubMed

Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23:1155–65.PubMedCentralCrossRefPubMed

Brzozowa M, Mielańczyk Ł, Michalski M, et al. The role of Notch signaling pathway in gastrin cancer pathogenesis. Contemp Oncol. 2013;17:1–5. doi:10.5114/wo.2013.33765

Brzozowa M, Wojnicz R, Kowalczyk-Ziomek G, Helewski K. The Notch ligand delta-like 4(DLL4) as a traget in angiogenesis-based cancer therapy. Contemp Oncol. 2013;17:234–7. doi:10.5114/wo.2013.35588

Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–28.CrossRefPubMed

10.

Yang MH, Hsu DS, Wang HW, et al. Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition. Nat Cell Biol. 2010;12:982–92. doi:10.1038/ncb2099CrossRefPubMed

11.

Kroepil F, Fluegen G, Totikov Z, et al. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas. PLoS One. 2012;7:e46665. doi:10.1371/journal.pone.0046665PubMedCentralCrossRefPubMed

12.

Pena C, Garcia JM, Larriba MJ, et al. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene. 2009;28:4375–85. doi:10.1038/onc.2009.285CrossRefPubMed

13.

Carver EA, Jiang R, LAN Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial–mesenchymal transition. Mol Cell Biol. 2001;21:8184–8.PubMedCentralCrossRefPubMed

14.

Koch U, Radtke F. Notch and cancer: a double-edged sword. Cell Mol Life. 2007;64:2746–62.CrossRef

15.

Borgrefe T, Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci. 2009;66:1631–46.CrossRef

16.

Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–33.PubMedCentralCrossRefPubMed

17.

Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006;107:2223–33.CrossRefPubMed

18.

Balόs V, Blanco M, Medina V, Aparicio G, Diaz-Prado S, Grande E. Notch signaling in cancer stem cells. Clin Transl Oncol. 2009;11:11–9.CrossRef

19.

Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelial–mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18:99–115. doi:10.1101/gad.276304PubMedCentralCrossRefPubMed

20.

Liu ZC, Wang HS, Zhang G, et al. AKT/GSK-3b regulates stability and transcription of snail which is crucial for bFGF-induced epithelial–mesenchymal transition of prostate cancer cells. Biochim Biophys Acta. 2014;1840:3096–105. doi:10.1016/j.bbagen.2014.07.018CrossRefPubMed

21.

Ma C, Wang J, Gao Y, et al. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res. 2007;67:7756–64.CrossRefPubMed

22.

Luna-Zurita L, Prados B, Grego-Bessa J, et al. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest. 2010;120:3493–507. doi:10.1172/JCI42666PubMedCentralCrossRefPubMed

23.

MacGrogan D, Luna-Zurita L, de la Pompa JL. Notch signaling in cardiac valve development and disease. Birth Defects Res A Clin Mol Teratol. 2011;91:449–59. doi:10.1002/bdra.20815CrossRefPubMed

24.

25.

Riley MF, McBride KL, Cole SE. NOTCH1 missense alleles associated with left ventricular outflow tract defects exhibit impaired receptor processing and defective EMT. Biochim Biophys Acta. 2011;1812:121–9. doi:10.1016/j.bbadis.2010.10.002PubMedCentralCrossRefPubMed

26.

Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res. 2010;107:429–41. doi:10.1161/CIRCRESAHA.110.218487PubMedCentralCrossRefPubMed

27.

Gupta N, Xu Z, El-Sehemy A, Steed H, Fu Y. Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells. Gynecol Oncol. 2013;130:200–6. doi:10.1016/j.ygyno.2013.03.019CrossRefPubMed

28.

Park JT, Chen X, Tropè CG, Davidson B, IeM S, Wang TL. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am J Pathol. 2010;177:1087–94. doi:10.2353/ajpath.2010.100316.28PubMedCentralCrossRefPubMed

29.

Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature. 2007;446:749–57.CrossRefPubMed

30.

Wang Z, Li Y, Kong D, et al. Acquisition of epithelial–mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 2009;69:2400–7. doi:10.1158/0008-5472.CAN-08-4312PubMedCentralCrossRefPubMed

31.

Jordà M, Olmeda D, Vinyals A, et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 2005;118:3371–85.CrossRefPubMed

32.

Zheng G, Lyons JG, Tan TK, et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial–mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol. 2009;175:580–91. doi:10.2353/ajpath.2009.080983PubMedCentralCrossRefPubMed

33.

Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial–mesenchymal transition. J Cell Biol. 2005;168:29–33.PubMedCentralCrossRefPubMed

34.

Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial–mesenchymal transition. Nat Cell Biol. 2004;6:931–40.CrossRefPubMed

35.

Chen X, Xiao W, Liu X, et al. Blockade of Jagged/Notch pathway abrogates transforming growth factor b2-induced epithelial–mesenchymal transition in human retinal pigment epithelium cells. Curr Mol Med. 2014;14:523–34.CrossRefPubMed

36.

Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810–20.PubMedCentralPubMed

37.

Luo D, Wang J, Li J, Post M. Mouse snail is a target gene for HIF. Mol Cancer Res. 2011;9:234–45. doi:10.1158/1541-7786.MCR-10-0214CrossRefPubMed

38.

Zhang L, Huang G, Li X, et al. Hypoxia induces epithelial–mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor—1a in hepatocellular carcinoma. BMC Cancer. 2013;13:108. doi:10.1186/1471-2407-13-108PubMedCentralCrossRefPubMed

39.

Ishida T, Hijioka H, Kume K, Miyawaki A, Nakamura N. Notch signaling induces EMT in OSCC cell lines in a hypoxic environment. Oncol Lett. 2013;6:1201–6.PubMedCentralPubMed

40.

41.

Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A. 2008;105:6392–7. doi:10.1073/pnas.0802047105PubMedCentralCrossRefPubMed

42.

Pietras A, von Stedingk K, Lindgren D, Påhlman S, Axelson H. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation. Mol Cancer Res. 2011;9:626–36. doi:10.1158/1541-7786.MCR-10-0508CrossRefPubMed

43.

Danza G, Serio C D, Rosati F, et al. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells. Mol Cancer Res. 2012;10:230–8. doi:10.1158/1541-7786.MCR-11-0296PubMedCentralCrossRefPubMed

44.

45.

Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006;13:1235–42.CrossRefPubMed

46.

Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A. 2007;104:7391–6.PubMedCentralCrossRefPubMed

47.

Li H, Wang H, Wang F, Gu Q, Xu X. Snail involves in the transforming growth factor b1-mediated epithelial–mesenchymal transition of retinal pigment epithelial cells. PLoS One. 2011;6:e23322. doi:10.1371/journal.pone.0023322PubMedCentralCrossRefPubMed

48.

Lv M, Li Y, Ji MH, Zhuang M, Tang JH. Inhibition of invasion and epithelial–mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Mol Med Rep. 2014;10:341–6. doi:10.3892/mmr.2014.2161PubMed

49.

Bao B, Li Y, Ahmad A, et al. Targeting CSC-related miRNAs for cancer therapy by natural agents. Curr Drug Targets. 2011;13:1858–68.CrossRef

50.

Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM. MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene. 2014;33:4069–76. doi:10.1038/onc.2013.369CrossRefPubMed

51.

Peng Y, Liu YM, Li LC, Wang LL, Wu XL. MicroRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition. Oncol Lett. 2014;7:1233–8.PubMedCentralPubMed

52.

Chen Z, Li S, Huang K, et al. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial–mesenchymal transition pathway. Hum Pathol. 2013;44:2097–105. doi:10.1016/j.humpath.2013.04.001CrossRefPubMed

Titel: The complex interplay between Notch signaling and Snail1 transcription factor in the regulation of epithelial–mesenchymal transition (EMT)
Notch and Snail1 in epithelial–mesenchymal transition (EMT)
verfasst von: M. Brzozowa-Zasada, PhD
A. Piecuch, MSc
O. Segiet, MD
Prof. K. Stęplewska
Prof. A. Gabriel
Prof. R. Wojnicz
Publikationsdatum: 01.10.2015
Verlag: Springer Vienna
Erschienen in: European Surgery / Ausgabe 5/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-015-0339-3

Springer Medizin Österreich

Summary

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Experience of colonic J pouch reconstruction following anterior resection

Transanal endoscopic microsurgery in treatment of small rectal T1 high-risk, T2 and T3 carcinomas combined with radiochemotherapy

The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma

Surgery, limos and shine keep things going

Vivian E. Strong (Ed) Gastric cancer: principles and practice

The knowledge of Polish medical students about surgical treatment of obesity